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THE PROLONGATION OF INSULIN ACTION
C. H. BEST,
Department of Physiology, University of Toronto
As an introduction to the consideration of the different forms
of insulin, which will be discussed later, a few remarks may be
made about the anti-diabetic material which was available in
1921. The administration of an effective dose of this material
caused a fairly prompt fall of the blood sugar to a low level.
The action was maintained for an appreciable length of time
(Fig. 1). It is readily apparent to physiologists, who have
worked with various preparations of insulin, that the crude
material available 16 years ago had a much more prolonged
action than the more highly purified preparations. While there
is considerable difficulty in making an accurate comparison of
materials used in .1922 and, let us say, in 1930, many clinicians
also agree that the crude preparations exerted a much more
prolonged effect than the solutions of the purified insulin. The
removal of impurities decreased the incidence of local reactions
at the site of the injection but did not improve insulin as a
specific therapeutic agent.
Insulin was available in a very satisfactory state of purity
before the substance was isolated in crystalline form. The
preparation of the crystals was, from the chemical viewpoint,
an extremely important landmark in the history of the develop-
ment of the subject. This was accomplished by Abel, Geiling,
Rouiller, Bell and Wintersteiner in 1927. The crystals occur in
several forms and are to some extent interconvertible. The
recent work of my colleague, D. A- Scott (1935, 1936), on the
r61e of zinc in the crystallization of insulin has placed the prep-
aration of these crystals on a more scientific basis. It is now a
relatively easy matter to obtain large amounts and a fair yield
(75 per cent or higher) from suitable amorphous material. The
crystalline material was termed by Scott "zinc insulinate."
Other metals may also be used in the preparation of the crystals
and these combine with insulin in amounts which are propor-
tional to their atomic weight. The average ash content of each
insulin salt is proportional to the atomic weight of the metal it
contains. This indicates that the crystals contain the metals as
chemically combined constituents and not as impurities, Scott
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and Fisher (1935) have found that if the molecular weight of
insulin be taken as 20,000 each formula weight of insulin com-
bines with 1.4 formula weights of cadmium, with 1.5 formula
weights of cobalt and 1.6 formula weights of zinc. If the
molecular weight of insulin should be 40,000 one formula weight
would therefore combine with approximately three formula
weights of the metals. Svedberg, using his ultracentrifuge
technique, has suggested 35,100 for the molecular weight of
insulin and Crowfoot, on the basis of X-ray studies, a value
of 37,200.
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Effect of insulin on the blood sugar curve of a depancreatized dog (redrawn from Banting and Best). (1) Injection of
extract of degenerated pancreas; (2) extract after incubation with pancreatic juice; (3) extract incubated without pancreatic juice.
Blood sugars by Myers-Bailey modification of Lewis-Benedict method.
FIGURE 1
The chemical structure of these crystals of insulin has
attracted a great deal of attention. This is not surprising since
there are relatively few crystalline proteins which can be so
readily assayed. An appropriate idea of the potency can be
obtained when only a few milligrams of the material are avail-
able. There is an abundance of evidence that the crystalline
material is protein in nature. Eight amino acids have also been
isolated—cystine, tyrosine, arginine, histidine, lysine, leucine,
glutamic acid and phenylalanine. Others are quite likely pres-
ent. In the search for the active groupings in the molecule
attention has been directed at the NH2 group and the disulphide
linkages. Destruction of the amino group irreversibly inac-
tivates insulin. When the disulphide grouping is reduced to the
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sulphydryl the specific activity is lost—some investigators
believe irreversibly while others think that a partial inactivation
which can be reversed may be produced. An insulin-plastein
may be formed when the products of peptic digestion of insulin
are allowed to interact under certain conditions but this, as
Scott considered likely before he performed the experiment,
possessed no anti-diabetic activity. The complexity of the
insulin molecule makes the possibility of synthesis remote.
The international yardstick for insulin is the new crystalline
standard. Fifty grams of crystals were prepared in the Con-
naught Laboratories by Dr. Scott and presented to the Health
Organization of the League of Nations by the Insulin Committee
of the University of Toronto. The potency of the new standard
was compared to that of the old amorphous preparation in a
number of laboratories. The results were submitted to repre-
sentatives of the National Institute for Medical Research, the
University of Copenhagen and the University of Toronto (rep-
resented by Sir Henry Dale, Professor August Krogh and the
writer). A recommendation was made that a value of 22 units
per mg. be assigned to this new standard. It was felt that this
would not change the strength of the unit. This recommenda-
tion was accepted by the Health Organization of the League of
Nations (1936). The unit of insulin is, therefore, defined as the
activity contained in %2 of a mg. (0.045 mg.) of the new
International Standard.
IMPROVING INSULIN AS A THERAPEUTIC AGENT
The advances recently made in this field have prompted me
to discuss it in some detail.
Various efforts were made in 1922 and 1923 to find a means
of administering insulin by the enteral route. Very little success
was secured, and if we now take all the reports on this problem
into account, the situation is approximately as follows: Insulin
is destroyed by the enzymes of the stomach and small intestine.
Small amounts of insulin may be absorbed from the small intes-
tine, particularly in young animals when very large doses are
given. The rate of absorption is not predictable. There is no
appreciable absorption from the large intestine. The situation
with respect to the absorption of insulin from other mucous
membranes is not more promising. An anti-diabetic effect can
be observed when an insulin solution is inhaled, but results of
practical value have not been secured. A very little insulin
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may be absorbed through the skin when vigorously rubbed in
with a lanoline base.
It is well known that the anti-diabetic hormone is rapidly
absorbed when given intraperitoneally, intramuscularly or sub-
cutaneously. The rate of action of purified insulin is only slightly
less when given subcutaneously than when administered into a
vein, and intramuscular injection does not appreciably delay
absorption. We can, therefore, restrict our discussion very
largely to the question of modification of the rate of action of
insulin which is administered subcutaneously.
As stated above there is an abundance of evidence to show
that crude insulin exerts a more prolonged effect than the puri-
fied material. It is also well established that a given amount of
insulin administered in several small doses exerts a greater
effect than when the same amount is administered in large
doses. This effect is due, probably, to the relatively large amount
of insulin excreted or destroyed when the large doses are
employed. These facts have stimulated investigators to attempt
to secure the prolongation of the absorption of insulin from the
subcutaneous tissue spaces. The first report of an attempt to do
this was that of Burgess, Campbell, Osman, Payne and Poulton
(1923), who used insulin in gum arabic solutions. These investi-
gators secured a definite prolongation of insulin action in dia-
betic patients and in experimental animals. Similar results
were obtained by de Jongh and Laqueur (1925). Leyton (1929)
convinced himself of the efficiency of insulin solutions mixed
with certain oils. He was able to give larger doses, and appar-
ently expected the use of oily suspensions of insulin to become
general. Suranyi and Szalai (1930) obtained a prolonged action
and less frequent hypoglycaemic reactions when insulin was
mixed with lecithin emulsions. Skouge and Schrumpf (1932)
confirmed the lecithin results and found, as might perhaps be
expected, that no extension of the insulin effect was obtained
when the mixtures were given intravenously. They found it
possible to administer subcutaneously large doses of insulin in
lecithin without the production of hypoglycaemic reactions.
Several groups of investigators—Wermer and Monguio (1933)
and Clausen (1934)—attempted to prolong the action of insulin
by administering pituitrin or epinephrin with the insulin solu-
tion. Little success attended these efforts.
Apparently the first attempt to modify the action of insulin
by the use of metals was that of Bertrand and Macheboeuf
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(1926). These investigators reported a very definite extension
of insulin action when cobalt and nickel were added to the
insulin solutions. This report led to the development of a con-
troversy, and the findings have not been generally confirmed.
We must not lose sight of the fact, however, that Bertrand and
his collaborator were the first to suggest the use of a metal in
this connection. The blood sugar curves which Maxwell and
Bischoff (1935) have published appear to indicate that basic
ferric chloride definitely slows the absorption of insulin. These
investigators have used other metals including zinc in their
studies of other hormones.
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FIGURE 2. (From Scott and Fisher.)
Scott and Fisher were led to a study of the action of zinc
salts on the rate of absorption of insulin by the findings referred
to above, that zinc, or some closely related metal, was an essen-
tial component of crystalline insulin. The addition of the
appropriate amount of zinc to insulin solution definitely delays
the absorption of insulin. It is possible that the zinc forms a
compound between the insulin and some component of the tis-
sues, or that the zinc solution delays the absorption of the
insulin by an astringent action or by some other mechanism.
Scott and Fisher have reported very definite findings in rabbits
(Fig. 2), and Dr. Kerr, working under my general direction, has
confirmed their findings in the dog (Fig. 3). Dr. Walter Camp-
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bell in Toronto and Dr. Rabinowitch in Montreal have recently
used zinc insulin in diabetic patients. A prolonged insulin effect
has been observed.
PROTAMINE INSULIN
This brings us to a consideration of protamine insulin which
has been used with very considerable success for more than
two years by Hagedorn (1936) and his colleagues in Copen-
hagen. The chemical background of this ingenious procedure
for delaying the absorption of insulin is most interesting and I
will now digress for a moment to discuss it.
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FIGURE 3. (From Kerr and Best.)
In 1868 Friedrich Miescher began an investigation of the
chemistry of cell nuclei. This work, conducted in Hoppe-
Seyler's laboratory, showed that proteins of acidic character
containing phosphoric acid were present in nuclei of pus cells.
Later he found these nuclions of nucleic acids in combination
with basic substances in the sperm of salmon. He named the
basic substances protamines. Some sixteen years later Kossel
detected another type of basic substance in combination with
nucleic acid. These were later shown to be similar to but some-
what more complex than the protamines. They are now called
the histones. Kossel also isolated a protamine from the sperm
of the sturgeon, which resembled but was not identical with the
base from salmon sperm. Protamine was adopted as the general
name for these bases while each separate one was called after
the family name of the fish from which it was secured—thus
sturine (sturgeon) etc. This protamine contains arginine, lysine
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and histidine, and is one of the triprotamines. Sturine also
contains alanine and leucine. Clupeine obtained from herring
sperm is a monoprotamine and contains arginine as the only
basic constituent. Alanine, serine, an aminovaleric acid, and
proline were also present. Salmine is also a monoprotamine and
contains serine, aminovaleric acid and proline as well as arginine.
Hagedorn and his colleagues have prepared a new protamine—
probably of the mono- variety—from the sperm of Salmo
irideus (salmiridine) and they have used this in their clinical
experiments, with protamine insulin.
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FIGURE 4. (From Scott and Fisher.)
Proteins are known to combine with the so-called protamines.
The compounds are soluble at a certain hydrogen ion concen-
tration, but insoluble at others. Hagedorn and his collab-
orators have very ingeniously taken advantage of this fact and
have demonstrated beyond doubt that the compound of insulin
and protamine is a very effective therapeutic agent in certain
cases. A clear solution of protamine is added to insulin. The
protamine is dissolved in a buffer solution of such a composition
that the hydrogen ion concentration of the insulin-protamine
mixture is approximately pH 7.2. At this pH the insulin-
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protamine compound is insoluble and forms a flocculent precip-
itate. If the vial containing the mixture is shaken and the sus-
pension administered, the insulin is slowly liberated in the
tissues and a prolonged anti-diabetic effect is exerted. That this
is due to slow absorption has been demonstrated directly by
Beecher and Krogh (1936) who watched the rate of disappear-
ance of regular and protamine insulin from the tissue spaces.
The effect of protamine insulin on rabbits or dogs is easily
demonstrated (Figs. 4 and 5).
It has now been agreed by most diabetic specialists that
protamine insulin has certain advantages over regular insulin
in many cases of diabetes. The advantages are as follows:
"3= 8 f S"
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FIGURE 5. (From Kerr and Best.)
(1) The duration of the anti-diabetic effect is longer with
protamine insulin than with the regular product. The number
of injections required is, therefore, reduced. (2) The blood
sugar curve is more regular and does not show the high peaks
and marked depressions which are often observed with the reg-
ular material. (3) The ketosis is reduced when protamine
insulin is used. (4) There are fewer hypoglycaemic reactions.
(5) The patients feel better.
ZINC AND PROTAMINE INSULIN
When the protamine solution is mixed with the insulin and
the insoluble precipitate formed, the resulting suspension of
protamine insulin is not stable indefinitely. It has been found
in the Connaught Laboratories and in the Insulin Committee's
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testing department that in some cases after a few days a portion
of the material sticks to the sides of the glass vial (Fig. 6) and
that it is impossible to secure samples of uniform potency. It
has been found by Scott and Fisher that this situation is cor-
rected by the addition of a small amount of zinc to the protamine
insulin mixture. The zinc in some way stabilizes the suspension
and prevents it sticking to the glass vial. If this were the only
effect of zinc it would be a very significant contribution but
there are grounds for belief that zinc plays a role in the formation
of a protamine insulin compound. Thus Scott and Fisher
showed (1936) that when preparations of insulin and protamine
from which inorganic material has been in large part removed
were mixed a prolonged anti-diabetic effect was not secured.
If, however, a small amount of zinc was present in this mixture,
a slow absorption of insulin and a prolonged action were con-
sistently produced. These results on rabbits have been confirmed
by Kerr and Best (1937) on dogs. (Fig. 7). This compound of
protamine and insulin to which zinc has been added has been
named by the Toronto group "protamine zinc insulin." The
use of zinc has made it possible to distribute the preparation in
one vial. The suspension is stable for at least six months and
perhaps for much longer periods of time. The protamine used
in the Connaught Laboratories has been prepared from the
mature testes of several species of British Columbia salmon,
namely, spring salmon (Oncorhynchus tschawytscha), cohoe
salmon (Oncorhyncus kisutch) and the steelhead (Salmo
gairdneri). These products are quite as satisfactory as those
secured from rainbow trout (Salmo irideus) and are readily
available in large quantities.
"FREE INSULIN" IN THE PROTAMINE ZINC INSULIN MIXTURE
Some clinicians have raised objections to the use of protamine
insulin and protamine zinc insulin on the grounds that they do
not exert their effects with sufficient rapidity. This has been
overcome by the administration of a small amount of regular
insulin with the protamine zinc insulin mixture. Quite recently
a preparation, made by Fisher and Scott, which contains in
addition to protamine zinc insulin a certain proportion of "free
insulin," has been tested by Kerr and McCutcheon under my
general direction in the Department of Physiology. It has
been found that a rapid effect comparable to that obtained
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action is also produced (Fig. 8). There are some difficulties to
be solved before a preparation of this kind suitable for clinical
use can be made but it seems probable that a mixture which
FIGURE 7 (upper); FIGURE 8 (lower), both from Kerr and Best.
will produce a rapid anti-diabetic effect and also a prolonged
one, will, in due course, be made available. Clinical trial of this
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PROTAMINE INSULIN IN DEPANCREATIZED DOGS
While the use of protamine insulin in diabetic patients had
been investigated in some detail before these experiments on
dogs were initiated considerable interest is attached to the
findings in a completely depancreatized animal. Dr. Kerr has
found it possible to keep several of the members of our colony of
diabetic dogs in an excellent state of health and on a very liberal
diet with one dose of protamine or protamine zinc insulin daily—
20 units approximately for a 10 kilogram dog. The animals
excrete only small amounts of sugar of the same order that are
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dose of regular insulin (20 units) is given at one injection large
amounts of sugar are excreted (Table 1, Kerr and Best). These
results provide additional evidence that a large part of the
insulin administered is excreted or otherwise lost when its
absorption is very rapid. As in human patients the fluctuations
of blood sugar throughout the day are largely eliminated and
the incidence of hypoglycaemic reactions is very definitely less
(Figs. 9 and 10). The results on diabetic dogs indicate that pro-
tamine insulin is a much more effective therapeutic agent than
regular insulin.
HYPOGLYCAEMIA AFTER INJECTIONS OF PROTAMINE INSULIN
Observations on diabetic dogs have shown, in confirmation
of clinical findings, that while the incidence of hypoglycaemic
reactions is less with protamine insulin than with regular insulin
those produced by the protamine preparations are often much
more severe. No difficulties are encountered when the hypo-
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glycaemia is treated immediately and plenty of sugar is made
available. It is apparent that the hypoglycaemia produced by
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FIGURE 9 (upper); FIGURE 10 (lower), both from Kerr and Best.
reason, more difficult to correct than that produced by unmod-
ified insulin. These findings emphasize the point that great care
should be taken to prevent hypoglycaemia when protamine
insulin or protamine zinc insulin is used.
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DIET AND PROTAMINE INSULIN COMPOUND
Since the effect of one injection of protamine zinc insulin
may persist for from 24 to 30 hours one dose per day may pro-
vide adequate insulin therapy in many clinical cases. This is the
objective which most clinicians have in view. Since this prep-
aration contains no appreciable amount of "free insulin" the
rapid utilization of sugar very soon after administration, which
is a characteristic effect of regular insulin, is not usually
observed. Furthermore, the time after injection at which the
lowest level of blood sugar is secured is much later than with
unmodified insulin. For these reasons clinicians have found it
necessary to make a redistribution of the food intake to provide
larger amounts of carbohydrate later in the day. By this
procedure a greater utilization of carbohydrate is secured and
the incidence of the late hypoglycaemic reactions *is decreased.
The reader is referred to the clinical literature for details of the
methods used.
SUMMARY
The results of Danish workers have made available a com-
pound of insulin and protamine which exerts a prolonged anti-
diabetic effect in cases of diabetes mellitus. Investigations
initiated in the University of Toronto have shown that zinc
may play an important r61e (1) in the stabilization of the
protamine insulin compound and (2) in further prolonging the
absorption of insulin. As a result of this series of studies a
protamine zinc insulin preparation of satisfactory potency and
stability, and contained in one vial, was made available for
clinical trial. This product has been tested in many diabetic
clinics'and is now generally used. It is possible that this prep-
aration may be further improved by the provision of a fixed
amount of "free insulin" in the mixture. Some of the problems
arising out of the use of these materials have been discussed.
Protamine insulin and protamine zinc insulin by enabling
clinical and laboratory investigators to procure a more uniform
and prolonged absorption of the anti-diabetic substance may
assist materially in the investigation of many problems in
carbohydrate metabolism.
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